We are live on ! Find out more
FG

Formula Growth Portfolio holdings

AUM $284M
1-Year Est. Return 54.56%
This Fund
S&P 500
This Quarter Est. Return
+39.63%
1 Year Est. Return
+54.56%
3 Year Est. Return
+117.67%
5 Year Est. Return
+78.26%
10 Year Est. Return
+276.27%
AUM
$284M
AUM Growth
+$62.7M
Cap. Flow
+$6.37M
Cap. Flow %
2.24%
Top 10 Hldgs %
22.84%
Holding
169
New
32
Increased
28
Reduced
43
Closed
24

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$3.23M
2
KVYO icon
Klaviyo
KVYO
+$2.49M
3
GH icon
Guardant Health
GH
+$2.1M
4
EQPT
EquipmentShare.com Inc
EQPT
+$1.66M
5
AVEX
AEVEX Corp
AVEX
+$1.53M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$6.75M
2
NOK icon
Nokia
NOK
+$3.54M
3
FPS
Forgent Power Solutions
FPS
+$2.4M
4
NAVN
Navan Inc
NAVN
+$1.85M
5
ARCB icon
ArcBest
ARCB
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 31.94%
2 Industrials 25.15%
3 Healthcare 16.98%
4 Consumer Discretionary 12.68%
5 Financials 4.41%

No holdings matched the selected filter criteria.

3 4 5 6 7

Similar funds

ATC
Advantage Trust Company Salina, Kansas $284M AUM 24.42% 1-Year Est. Return
MWM
MBE Wealth Management Tomah, Wisconsin $284M AUM 22.67% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $284M AUM 27.28% 1-Year Est. Return
BP
Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
1W
1776 Wealth Atlanta, Georgia $284M AUM 21.82% 1-Year Est. Return
WMA
William Mack & Associates Troy, Michigan $284M AUM 19.06% 1-Year Est. Return
CWA
Choice Wealth Advisors Waterville, Maine $285M AUM 19.08% 1-Year Est. Return

Formula Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Formula Growth held 169 positions worth $284M, up 28% from $222M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Formula Growth's Q2 2026 filing shows 32 new, 28 increased, 43 reduced and 24 closed positions. Its largest new stake was Guardant Health: 19,300 shares worth $2.9M. The largest sale was Micron Technology, an estimated $6.75M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Formula Growth's largest Q2 2026 buy was Guardant Health: 19,300 shares worth $2.9M.
  • Formula Growth added most to Calix in Q2 2026, an estimated $3.23M increase.
  • Formula Growth's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $6.75M.
  • Formula Growth fully exited Navan Inc in Q2 2026, selling an estimated $1.85M.
  • Formula Growth's ten largest holdings make up 23% of its $284M portfolio in Q2 2026.
  • Formula Growth opened 32 new positions and closed 24 in Q2 2026.
  • Formula Growth's portfolio value rose 28% quarter-over-quarter to $284M.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.